Skip to Content


In the US, Ustekinumab (ustekinumab systemic) is a member of the drug class interleukin inhibitors and is used to treat Crohn's Disease, Psoriasis and Psoriatic Arthritis.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories


Interleukin Inhibitor

Chemical Name

Immunoglobulin G1, anti-[Homo sapiensinterleukin 12B (IL12B, IL12 p40, natural killer cell stimulatory factor 2, NKSF2, cytotoxic lymphocyte maturation factor 2, CLMF2, CMLF p40)], Homo sapiensmonoclonal antibody, CNTO 1275; gamma1 heavy chain (1-449) [Ho (WHO )

Foreign Names

  • Ustekinumabum (Latin)
  • Ustekinumab (German)
  • Ust├ękinumab (French)
  • Ustekinumab (Spanish)

Generic Names

Brand Names

  • Stelara
    Centocor, United States; J.C. Healthcare, Israel; Janssen, Australia; Janssen, Brazil; Janssen, Canada; Janssen, Chile; Janssen, Finland; Janssen, Hong Kong; Janssen, Hungary; Janssen, Ireland; Janssen, Iceland; Janssen, Malaysia; Janssen, Norway; Janssen, New Zealand; Janssen, Romania; Janssen, Singapore; Janssen, Slovenia; Janssen, Slovakia; Janssen, Thailand; Janssen, South Africa; Janssen Bio, Netherlands; Janssen Cilag, Argentina; Janssen Cilag, Serbia; Janssen Pharmaceutical, Japan; Janssen-Cilag, Belgium; Janssen-Cilag, Colombia; Janssen-Cilag, Czech Republic; Janssen-Cilag, Germany; Janssen-Cilag, Denmark; Janssen-Cilag, France; Janssen-Cilag, United Kingdom; Janssen-Cilag, Greece; Janssen-Cilag, Italy; Janssen-Cilag, Lithuania; Janssen-Cilag, Latvia; Janssen-Cilag, Mexico; Janssen-Cilag, Poland; Janssen-Cilag, Portugal; Janssen-Cilag International, Austria; Johnson & Johnson, Croatia (Hrvatska); Johnson & Johnson, Indonesia; Johnson & Johnson, Turkey
    Janssen-Cilag, Switzerland


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.